Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Protein engineering, design & selection : PEDS

• Publication date

  2004-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/PROTEIN/GZH055PMID 15235124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug Delivery Systems: Entering the Mainstream

  2004cited by this paper
• Molecular Role(s) for Integrins in Human Melanoma Invasion

  2004cited by this paper
• Use of phage display to probe the evolution of binding specificity and affinity in integrins.

  2003cited by this paper
• Peptide-targeted PEG-liposomes in anti-angiogenic therapy.

  2003cited by this paper
• The first international conference on vascular targeting: meeting overview.

  2003cited by this paper
• Engineered Fibronectin Type III Domain with a RGDWXE Sequence Binds with Enhanced Affinity and Specificity to Human αvβ3 Integrin

  2003cited by this paper
• Phage Display of Random Peptide Libraries: Applications, Limits, and Potential

  2003cited by this paper
• Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.

  2003cited by this paper
• Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.

  2003cited by this paper
• Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study

  2002cited by this paper
• Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

  2002cited by this paper
• Therapeutic cancer targeting peptides.

  2002cited by this paper
• Highly efficient transduction of endothelial cells by targeted artificial virus-like particles

  2001cited by this paper
• Solution structures and integrin binding activities of an RGD peptide with two isomers.

  2001influential reference
• Molecular addresses in blood vessels as targets for therapy.

  2001cited by this paper
• Antibody-based targeting of angiogenesis.

  2001cited by this paper
• Neovascular Targeting with Cyclic RGD Peptide (cRGDf-ACHA) to Enhance Delivery of Radioimmunotherapy

  2000cited by this paper
• Alpha(v)beta3 expression on blood vessels and melanoma cells in primary lesions: differential association with tumor progression and clinical prognosis.

  2000cited by this paper
• αvβ3 expression on blood vessels and melanoma cells in primary lesions; differential association with tumor progression and clinical prognosis

  2000cited by this paper
• Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display.

  2000cited by this paper
• Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

  1999cited by this paper
• Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway

  1999cited by this paper
• Immunoliposomes for the targeted delivery of antitumor drugs.

  1999cited by this paper
• Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins.

  1999cited by this paper
• Structural Requirements of Echistatin for the Recognition of αvβ3 and α5β1Integrins*

  1999cited by this paper
• Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.

  1998cited by this paper
• Ligand-targeted liposomes.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Antiangiogenic tumour therapy: will it work?

  1998cited by this paper
• αv Integrins as receptors for tumor targeting by circulating ligands

  1997cited by this paper
• Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins

  1997cited by this paper
• Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

  1997cited by this paper
• Integrins and cancer.

  1996cited by this paper
• Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins

  1995influential reference
• Site-directed mutagenesis of the arginine-glycine-aspartic acid in vitronectin abolishes cell adhesion.

  1993cited by this paper
• Human endothelial cells express integrin receptors on the luminal aspect of their membrane.

  1992cited by this paper
• Integrin expression in human melanoma cells with differing invasive and metastatic properties

  1992cited by this paper
• Integrin expression in malignant melanoma

  1991cited by this paper
• Biopolymers

  1984cited by this paper
• Lectin-mediated aggregation of liposomes containing glycolipids with variable hydrophilic spacer arms.

  1980cited by this paper
• CIRCULATION

  1964cited by this paper
• Technology

  1929influential reference

• From Transient to Stable: Incorporating Electrophiles in Genetically-Encoded and DNA-Encoded Libraries of Peptide-Derived Macrocycles.

  2026cites this paper
• Formulation methods for peptide-modified lipid nanoparticles.

  2025cites this paper
• A Two-Step Synthesis of Covalent Genetically-Encoded Libraries of Peptide-Derived Macrocycles (cGELs) enables use of electrophiles with diverse reactivity

  2025cites this paper
• Emerging innovations in nanomedicine for cancer immunotherapy

  2025cites this paper
• Advances in Preclinical Research of Theranostic Radiopharmaceuticals in Nuclear Medicine.

  2025cites this paper
• Applications and Efficacy of Iron Oxide Nanoparticles in the Treatment of Brain Tumors

  2025cites this paper
• Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability

  2025cites this paper
• Navigating cancer therapy: Harnessing the power of peptide-drug conjugates as precision delivery vehicles.

  2024cites this paper
• Late-Stage Reshaping of Phage-Displayed Libraries to Macrocyclic and Bicyclic Landscapes using a Multipurpose Linchpin.

  2024cites this paper
• Modified Bacteriophage for Tumor Detection and Targeted Therapy

  2023cites this paper
• In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications

  2023cites this paper
• Vasculature organotropism in drug delivery.

  2023cites this paper
• Evaluation and manipulation of tissue and cellular distribution of cardiac progenitor cell-derived extracellular vesicles

  2022influential citation
• Peptide therapeutics in the management of metastatic cancers

  2022cites this paper
• Advances in lipid-based nanocarriers for breast cancer metastasis treatment

  2022cites this paper
• Using peptides to promote delivery and improve anti-tumour efficacy of liposomal drug

  2021cites this paper
• RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy via multiple tumorous targeting

  2021cites this paper
• A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation

  2021cites this paper
• Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer

  2021cites this paper
• Targeting the undruggable: emerging technologies in antibody delivery against intracellular targets

  2020cites this paper
• Grand challenges in nanomedicine.

  2020cites this paper
• A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome.

  2020cites this paper
• ANTIINTEGRIN AVG3 SAV-RGD AS COMBINANT FOR DTIC WITH HUMAN AMELANOTIC SKIN MELANOMA

  2019influential citation
• ANTITUMOR ACTIVITY OF ANTI-INTEGRIN PROTEIN SAV-RGD ON XENOGRAFTED HUMAN SKIN MELANOMA WITH INTEGRIN AVG3 EXPRESSION

  2019cites this paper
• Synthesis of Modified RGD‐Based Peptides and Their in vitro Activity

  2019cites this paper
• Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10–NGR9 ultrasmall superparamagnetic iron oxide nanoparticles

  2018cites this paper
• What about αvβ3 integrins in molecular imaging in oncology?

  2018cites this paper
• Dual integrin αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging

  2018cites this paper
• Grafting Onto Biopolymers: Application in Targeted Drug Delivery

  2018cites this paper
• Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration

  2017cites this paper
• Effect of PEGylation on Ligand-Targeted Magnetoliposomes: A Missed Goal

  2017cites this paper
• Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides

  2017cites this paper
• A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins

  2017cites this paper
• Peptide-Based Cancer-Targeted DDS and Molecular Imaging.

  2017cites this paper
• Hierarchical Nanocarriers for Precisely Regulating the Therapeutic Process via Dual-Mode Controlled Drug Release in Target Tumor Cells.

  2017cites this paper
• Sub-20 nm Stable Micelles Based on a Mixture of Coiled-Coils: A Platform for Controlled Ligand Presentation.

  2017cites this paper
• Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells

  2016cites this paper
• Anti-angiogenic Therapy by Targeting the Tumor Vasculature with Liposomes

  2016cites this paper
• Coupling of Peptides to the Surface of Liposomes— Application to Liposome-Based Synthetic Vaccines

  2016cites this paper
• Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.

  2016cites this paper
• Intracellular Delivery III

  2016cites this paper
• Dual‐drug RGD conjugates provide enhanced cytotoxicity to melanoma and non‐small lung cancer cells

  2016cites this paper
• RGD-based Therapy: Principles of Selectivity.

  2016cites this paper
• Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel.

  2016cites this paper
• Selection of Phage Display Peptides Targeting Human Pluripotent Stem Cell-Derived Progenitor Cell Lines.

  2016cites this paper
• In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150Glued

  2016cites this paper
• Nanoscale drug delivery for targeted chemotherapy.

  2016cites this paper
• Integrin Targeting Using RGD-Based Peptide Amphiphiles

  2015cites this paper
• Non-Invasive Detection of Lung Inflammation by Near-Infrared Fluorescence Imaging Using Bimodal Liposomes

  2015cites this paper
• Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging

  2015cites this paper
• Impact of RGD Peptide Tethering to IL24/mda-7 (Melanoma Differentiation Associated Gene-7) on Apoptosis Induction in Hepatocellular Carcinoma Cells.

  2015cites this paper
• Impact of RGD Peptide Tethering to IL24/mda-7 (Melanoma Differentiation Associated Gene-7) on Apoptosis Induction in Hepatocellular Carcinoma Cells

  2015cites this paper
• Systemic Administration of siRNA via cRGD-containing Peptide

  2015cites this paper
• Review peptide‐targeted liposomes for selective drug delivery: Advantages and problematic issues

  2015cites this paper
• Colon Targeted Liposomal Systems (CTLS): Theranostic Potential.

  2015cites this paper
• Ligand-targeted liposome design: challenges and fundamental considerations.

  2014cites this paper
• Bacteriophage-Targeted Nanomedicine and Molecular Imaging

  2014cites this paper
• Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery.

  2014cites this paper
• Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft models

  2014cites this paper
• Enhancement of the uptake and cytotoxic activity of doxorubicin in cancer cells by novel cRGD-semipeptide-anchoring liposomes.

  2014cites this paper
• Tumor Vasculature-Targeted Recombinant Mutated Human TNF-α Enhanced the Antitumor Activity of Doxorubicin by Increasing Tumor Vessel Permeability in Mouse Xenograft Models

  2014cites this paper
• Expression, Purification, and Characterization of Scar Tissue Neovasculature Endothelial Cell-Targeted rhIL10 in Escherichia Coli

  2014cites this paper
• Ligation Strategies for Targeting Liposomal Nanocarriers

  2014cites this paper
• The development of site-specific drug delivery nanocarriers based on receptor mediation.

  2014cites this paper
• Paclitaxel-Loaded PEG-PE–Based Micellar Nanopreparations Targeted with Tumor-Specific Landscape Phage Fusion Protein Enhance Apoptosis and Efficiently Reduce Tumors

  2014cites this paper
• Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.

  2014cites this paper
• Bioengineering strategies for designing targeted cancer therapies.

  2013cites this paper
• Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas.

  2013cites this paper
• Identification of Human Embryonic Progenitor Cell Targeting Peptides Using Phage Display

  2013cites this paper
• Needle-free gene delivery through the skin: an overview of recent strategies.

  2013cites this paper
• Preparation and functional evaluation of RGD-modified streptavidin targeting to integrin-expressing melanoma cells.

  2013influential citation
• Landscape phage fusion protein-modified pharmaceutical nanocarriers for targeted and cytoplasmic delivery of chemotherapeutics to breast cancer cells in vitro and in vivo

  2012cites this paper
• Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles

  2012cites this paper
• Integrin-mediated drug delivery in cancer and cardiovascular diseases with peptide-functionalized nanoparticles.

  2012cites this paper
• Nasal and Pulmonary Delivery of Macromolecules to Treat Respiratory and Nonrespiratory Diseases

  2012cites this paper
• Challenges in Development of Nanoparticle-Based Therapeutics

  2012cites this paper
• Development of Hydrogels and Biomimetic Regulators as Tissue Engineering Scaffolds

  2012cites this paper
• Development of polymer and lipid based nano-delivery systems for targeted cancer chemotherapy

  2012cites this paper
• Fatty Acid–RGD Peptide Amphiphile Micelles as Potential Paclitaxel Delivery Carriers to αvβ3Integrin Overexpressing Tumors

  2012cites this paper
• Targeted Delivery to the Pulmonary Endothelium

  2012cites this paper
• Novel Synergistic Therapy for Metastatic Breast Cancer: Magnetic Nanoparticle Hyperthermia of the Neovasculature Enhanced by a Vascular Disruption Agent

  2012cites this paper
• Integrin Targeted Delivery of Chemotherapeutics

  2011influential citation
• Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid

  2011cites this paper
• RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies.

  2011cites this paper
• Peptide‐labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells

  2011cites this paper
• On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence matters.

  2011cites this paper
• Integrin-targeted paclitaxel nanoliposomes for tumor therapy

  2011cites this paper
• Quantitative In Vivo Assessment of Tumour Vasculature-targeted Liposomes

  2011cites this paper
• Magnetic resonance imaging contrast agent: cRGD-ferric oxide nanometer particle and its role in the diagnosis of tumor.

  2011cites this paper
• Anti-tumor efficacy and pre-clinical immunogenicity of IFNα2a-NGR.

  2011cites this paper
• Development of an intrabody capable of activating interferon regulatory factor-1 [IRF-1] and identification of IRF-1-binding peptide motifs

  2011cites this paper
• Lactadherin-derived peptides as antiviral agents

  2011cites this paper
• Integrin Targeted Delivery of Radiotherapeutics

  2011influential citation
• Vitronectin-Binding Integrins in Cancer

  2010cites this paper
• Development and Evaluation of Paclitaxel-Loaded Liposomal Formulations for Targeted Drug Delivery to Breast Cancer

  2010cites this paper
• Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.

  2010cites this paper
• Integrin targeted drug and gene delivery

  2010cites this paper
• Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes

  2010cites this paper
• Targeting alphavbeta3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides.

  2010cites this paper
• Liposomal cancer therapy: exploiting tumor characteristics

  2010cites this paper